1d
News Medical on MSNDisrupting the RBM42 protein could throw a wrench in the gears of cancer's growthFor decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many ...
For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many cancers manage to overcome this and continue growing. Now, scientists think they ...
The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...
Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...
Republican Rep. Brandon Shippy wants to put a moratorium on mRNA vaccines, based on his ignorance about them. | Opinion ...
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed ...
Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that encodes for ...
To demonstrate the concept, Prof. Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA, encapsulated it in lipid nanoparticles with a composition different from those ...
During translation, ribosomes can pause on the nucleic acid. Researchers showed that collisions from incoming proteins get ...
Ethris Presents Positive Topline Phase 1 Data with mRNA Lead Candidate ETH47 for Uncontrolled Asthma
Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced promising topline data from the completed Phase 1 clinical trial of its lead mRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results